Indefinite Delivery Contract SPE2DR25D1022

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
The federal contract IDV award SPE2DR25D3007 is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract runs through December 31, 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DR25D1907 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities including specialty medications, brand-name and...
The federal contract IDV award SPE2DR25D7059 is a $999,999,999 Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. This single-award contract runs through December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
The federal contract IDV award SPE2DR25D6041, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The federal contract IDV award, SPE2DR25D1992, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2036. The contract's purpose is to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide...
The federal contract IDV award SPE2DR25D3304 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, has a period of performance through December 31, 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DR25D2102 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has an ultimate completion date of December 31, 2036 and supports the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide...
The federal contract IDV award SPE2DR25D3801 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2036. The IDC serves as a primary vehicle for...

The federal contract IDV award SPE2DR25D1022 is a single-award Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally.

The contract, which runs through December 2036, is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contract covers an extensive array of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, supporting normal day-to-day operations as well as contingency and readiness requirements for both CONUS and OCONUS locations.

Generated 6/6/25, 9:55 AM